NurseJet
Back to Discover
Research ArticleResearchPatient Education

AF ablation did not outperform a sham procedure for quality of life at six months

Lancet (PubMed)Sep 12, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

A double-blind randomized trial found that catheter ablation did not demonstrate superiority over a sham procedure for improving atrial-fibrillation-related quality of life at six months.

What NurseJet pulled from the source

Among 262 adults, quality-of-life scores improved in both groups. The estimated between-group difference in change was 2.6 points (95% CI -2.7 to 8.0; p=0.36).

Why this matters for nurses

The sham-controlled design helps separate a procedure-specific quality-of-life effect from improvement associated with participation and procedural context. The result concerns the six-month quality-of-life endpoint, not every potential outcome of ablation.

Bedside takeaway

Frame this as a six-month quality-of-life result and maintain standard post-procedure monitoring.

Key takeaways

  • Participants had symptomatic paroxysmal or persistent atrial fibrillation and were randomized 2:1 to ablation or a sham procedure.
  • One death occurred in each group, and neither was considered related to the study procedure.
  • Procedure-related or possibly procedure-related serious adverse events occurred in six ablation participants and four sham participants.

Practice implications

  • When educating patients around AF ablation, describe the study's quality-of-life finding in context and continue standard rhythm, symptom, access-site, and complication surveillance under the cardiology pathway.

Limitations & cautions

  • Abstract-only summary. Follow-up for the primary endpoint was six months, 12-month follow-up was ongoing, and the abstract does not establish effects on longer-term rhythm control or other clinical outcomes.
  • AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

Lancet (PubMed)

Lancet (PubMed). Catheter ablation for symptomatic atrial fibrillation (PVI-SHAM-AF): a randomised, double-blind, sham-controlled, multicentre trial.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42669307/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Family Medicine and Community Health (PubMed)

A dose-response meta-analysis of prospective cohorts found that higher ultra-processed food intake was associated with higher risks of cardiovascular events, cancer, obesity or overweight, metabolic syndrome or diabetes, depression or anxiety, digestive disease, and all-cause mortality.

Med-SurgTelemetryAI summaryReview source

Journal of Clinical Nursing (PubMed)

A mixed-methods systematic review found that nurses viewed situational awareness, teamwork, communication, leadership, experience, intuition, and freedom from retribution as important to recognizing and escalating clinical deterioration.

LeadershipMed-SurgAI summaryReview source

Journal of Advanced Nursing (PubMed)

A systematic review and meta-analysis found moderate-certainty evidence that nurse-led or nurse-coordinated multicomponent nonpharmacologic programs reduced delirium incidence in hospitalized adults aged 60 or older.

GeriatricsMed-SurgAI summaryReview source